What Researchers Did
Researchers conducted a prospective observational study on 73 patients with Stage I or II avascular necrosis of the femoral head to evaluate the effect of hyperbaric oxygen therapy on their quality of life.
What They Found
All 73 patients, with a mean age of 40.34 years, participated in the study. Significant improvements were observed in quality of life measures, including the Steinberg scale, EuroQol-5D-5L, Harris Hip Score, MAHORN, and VAS scores, between the first and second measurements after hyperbaric oxygen therapy. These improvements were noted after both 20 and 40 sessions of therapy.
What This Means for Canadian Patients
For Canadian patients with early-stage avascular necrosis of the femoral head, hyperbaric oxygen therapy may offer a non-invasive option to improve pain and overall quality of life. This could potentially delay or reduce the need for more invasive surgical interventions.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
A key limitation of this study is its non-controlled observational design, which prevents definitive conclusions about the efficacy of hyperbaric oxygen therapy compared to other treatments or no treatment.